0

Journal Articles

in Diabetes Mellitus Treatment
 21-40 of 292 Articles
JAMA Dermatology | 
Study |  September 01, 2012
Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With Psoriasis
Rahat S. Azfar, MD; Nicole M. Seminara, MD; Daniel B. Shin, BA; et al.
Arch Dermatol. 2012;148(9):995. doi:10.1001/archdermatol.2012.1401.
JAMA Internal Medicine | 
Correction |  July 23, 2012
Error in Text in: Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
Arch Intern Med. 2012;172(14):1095. doi:10.1001/archinternmed.2012.3617.
JAMA Pediatrics | 
Editorial |  July 01, 2012
Vitamin D3 Supplementation to Preserve Pancreatic β-Cell Function in Newly Diagnosed Type 1 Diabetic Patients
Sheela N. Magge, MD, MSCE
Arch Pediatr Adolesc Med. 2012;166(7):664-666. doi:10.1001/archpediatrics.2012.500.
JAMA Pediatrics | 
Article |  July 01, 2012
Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
Mônica A. L. Gabbay, MD, PhD; Maria N. Sato, MD, PhD; Claudia Finazzo, MS(Biomed); et al.
Arch Pediatr Adolesc Med. 2012;166(7):601-607. doi:10.1001/archpediatrics.2012.164.
JAMA | 
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
JAMA | 
Medical News and Perspectives |  June 06, 2012
Guidelines Ease Up on Glycemic Control for Some Patients With Type 2 Diabetes
Mike Mitka
JAMA. 2012;307(21):2243-2244. doi:10.1001/jama.2012.5242.
JAMA Internal Medicine | 
Invited Commentary |  May 28, 2012
Prioritizing Treatments in Type 2 Diabetes Mellitus:  Comment on “Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus”
Karen L. Margolis, MD, MPH; Patrick J. O’Connor, MD, MA, MPH
Arch Intern Med. 2012;172(10):770-772. doi:10.1001/archinternmed.2012.1775.
JAMA Internal Medicine | 
Invited Commentary |  May 28, 2012
Understanding the Long-term Benefits and Dangers of Intensive Therapy of Diabetes:  Comment on “Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus”
David M. Nathan, MD
Arch Intern Med. 2012;172(10):769-770. doi:10.1001/archinternmed.2012.438.
JAMA Internal Medicine | 
Review Article |  May 28, 2012 FREE
Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus:  Systematic Review and Meta-analysis
Steven G. Coca, DO, MS; Faramarz Ismail-Beigi, MD, PhD; Nowreen Haq, MD, MPH; et al.
Arch Intern Med. 2012;172(10):761-769. doi:10.1001/archinternmed.2011.2230.
INCLUDES: CME , Supplemental Content
JAMA Neurology | 
Correspondence |  May 01, 2012
Insulin and Alzheimer Disease
Arch Neurol. 2012;69(5):670-671. doi:10.1001/archneurol.2012.42.
JAMA Neurology | 
Correspondence |  May 01, 2012
Insulin and Alzheimer Disease—Reply
Arch Neurol. 2012;69(5):670-671. doi:10.1001/archneurol.2012.45.
JAMA | 
Medical News & Perspectives |  April 25, 2012
Media Lab Uses Videos, Comics, and More to Help People Understand Health Issues
Tracy Hampton, PhD
JAMA. 2012;307(16):1679-1680. doi:10.1001/jama.2012.507.
JAMA Internal Medicine | 
Editor's Correspondence |  April 09, 2012
Association Between Glycemic Control and Adverse Outcomes in Diabetic Patients With CKD
Arch Intern Med. 2012;172(7):597-598. doi:10.1001/archinternmed.2012.129.
JAMA Internal Medicine | 
Editor's Correspondence |  April 09, 2012
Association Between Glycemic Control and Adverse Outcomes in Diabetic Patients With CKD—Reply
Arch Intern Med. 2012;172(7):597-598. doi:10.1001/archinternmed.2012.227.
JAMA | 
Health Agencies Update |  February 22, 2012
Insulin Pen Reminder
Bridget M. Kuehn
JAMA. 2012;307(8):773. doi:10.1001/jama.2012.175.
JAMA Internal Medicine | 
Editor's Correspondence |  February 13, 2012
Experience Is a Gloomy Lantern That Does Not Even Illuminate Its Bearer
Alain Braillon, MD, PhD
Arch Intern Med. 2012;172(3):294. doi:10.1001/archinternmed.2011.760.
JAMA Neurology | 
Clinical Trials |  January 01, 2012 FREE
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment:  A Pilot Clinical Trial
Suzanne Craft, PhD; Laura D. Baker, PhD; Thomas J. Montine, MD, PhD; et al.
Arch Neurol. 2012;69(1):29-38. doi:10.1001/archneurol.2011.233.
INCLUDES: CME , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  December 12, 2011
Improving Glycemic Control When “Usual” Diabetes Care Is Not Enough:  Comment on “The Effect of a Structured Behavioral Intervention on Poorly Controlled Diabetes”
Ralph Gonzales, MD, MSPH; Margaret A. Handley, PhD, MPH
Arch Intern Med. 2011;171(22):1999-2000. doi:10.1001/archinternmed.2011.496.
JAMA Internal Medicine | 
Invited Commentary |  November 28, 2011
Glycemic Control and Cardiorenal Outcomes in Patients With Advanced Chronic Kidney Disease: Relative or Absolute Risks?:  Comment on “Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease”
David C. Goff, MD, PhD
Arch Intern Med. 2011;171(21):1927-1928. doi:10.1001/archinternmed.2011.520.
JAMA Internal Medicine | 
Research Letters |  November 28, 2011 FREE
Improvement of Quality of Life With Supervised Exercise Training in Subjects With Type 2 Diabetes Mellitus
Antonio Nicolucci, MD; Stefano Balducci, MD; Patrizia Cardelli, PhD; et al.
Arch Intern Med. 2011;171(21):1951-1953. doi:10.1001/archinternmed.2011.561.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA
Health Agencies Update  |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
JAMA Internal Medicine
Editorial  |  April 22, 2013
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Internal Medicine
Original Investigation  |  February 25, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems